News and updates

Brief updates from Sydney Health Law: research, media appearances, events and our community. Linked titles lead to the original story; other updates can be read here.

Research · The University of Sydney

How leading hospitals could make every experimental treatment count

Christopher Rudge and Wojciech Chrzanowski discuss how hospitals can turn experimental treatments into opportunities for learning. The feature examines the hospital exclusion for human cells and tissues, and the governance needed to document outcomes and share knowledge.

Christopher Rudge and Wojciech Chrzanowski in a laboratory
Christopher Rudge and Wojciech Chrzanowski. Photo: University of Sydney.

22 July 2026

Public health, science and trust in the Trump era ↗

Lawrence Gostin joined Julie Leask and Andrew Wilson to discuss US public health policy and its implications for Australia. The University’s centre page includes a recording.

21 July 2026

Terry Carney receives a lifetime achievement award ↗

The Council of Australian Law Deans recognised Terry Carney’s contributions to legal scholarship, teaching and law reform across more than five decades.

Terry Carney
Terry Carney. Photo: University of Sydney.

30 September 2025

Public health law and the climate crisis ↗

Belinda Reeve considers how public health law can respond to climate change and the risks it poses to health.

Belinda Reeve
Belinda Reeve. Photo: University of Sydney.

30 September 2025

Fair access to gene therapies ↗

Cameron Stewart’s research examines how decisions about access to genomic therapies can be fairer and more transparent.

Cameron Stewart
Cameron Stewart. Photo: University of Sydney.

30 September 2025

The law of tomorrow’s medicines ↗

Christopher Rudge explores the legal questions raised by psychedelics, nanomedicine and stem cell models as research moves towards new clinical possibilities.

Christopher Rudge
Christopher Rudge. Photo: University of Sydney.

9 September 2025

Access to medicines in a globalised world ↗

Olugbenga Olatunji examines how international intellectual property rules affect access to medicines in vulnerable regions.

Olugbenga Olatunji
Olugbenga Olatunji. Photo: University of Sydney.

More from the research centre ↗ · Follow Sydney Health Law on LinkedIn ↗